Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
GLP-1 patches: weight loss patches explained Medically reviewed by Dr Kathryn Basford Last reviewed: 19 Jun 2026 GLP-1 weight loss patches have recently seen a rise in popularity and social media attention
FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
Anticipated improvements post-treatment may include a gradual lightening of the skin, reduction in blemishes or spots, and an overall clearer complexion
GLP-1s Show Promise for Mental Health Beyond weight loss, emerging research suggests GLP-1 receptor agonists might have direct mental health benefits: Reduced binge-eating and food cravings in patients with BED and obesity Lower rates of substance use in preliminary studies (reduced alcohol and nicotine cravings) Improved mood and quality-of-life scores independent of weight loss No increase in depression or suicidality (the FDA and EMA both reviewed this and found no causal link) In fact, large trials like the STEP studies showed slightly lower rates of depressive symptoms in GLP-1-treated groups compared to placebo
